These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1314 related articles for article (PubMed ID: 22436800)
1. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery. Liu P; Yu H; Sun Y; Zhu M; Duan Y Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800 [TBL] [Abstract][Full Text] [Related]
2. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer. Liu P; Qin L; Wang Q; Sun Y; Zhu M; Shen M; Duan Y Biomaterials; 2012 Oct; 33(28):6739-47. PubMed ID: 22763223 [TBL] [Abstract][Full Text] [Related]
3. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer. Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487 [TBL] [Abstract][Full Text] [Related]
4. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel. Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053 [TBL] [Abstract][Full Text] [Related]
5. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411 [TBL] [Abstract][Full Text] [Related]
6. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil. Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486 [TBL] [Abstract][Full Text] [Related]
7. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery. Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197 [TBL] [Abstract][Full Text] [Related]
8. Biodegradable copolymers with identical cationic segments and their performance in siRNA delivery. Qi R; Liu S; Chen J; Xiao H; Yan L; Huang Y; Jing X J Control Release; 2012 Apr; 159(2):251-60. PubMed ID: 22285552 [TBL] [Abstract][Full Text] [Related]
9. Dendritic poly(L-lysine)-b-Poly(L-lactide)-b-dendritic poly(L-lysine) amphiphilic gene delivery vectors: roles of PLL dendritic generation and enhanced transgene efficacies via termini modification. Li Y; Zhu Y; Xia K; Sheng R; Jia L; Hou X; Xu Y; Cao A Biomacromolecules; 2009 Aug; 10(8):2284-93. PubMed ID: 19586045 [TBL] [Abstract][Full Text] [Related]
10. Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas. Liu P; Sun Y; Wang Q; Sun Y; Li H; Duan Y Biomaterials; 2014 Jan; 35(2):760-70. PubMed ID: 24148242 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of biodegradable cationic triblock copolymer mPEG-PCL-PLL for siRNA delivery. Qi R; Hu X; Yan L; Chen X; Huang Y; Jing X J Control Release; 2011 Nov; 152 Suppl 1():e167-8. PubMed ID: 22195827 [No Abstract] [Full Text] [Related]
12. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment. Wang J; Feng SS; Wang S; Chen ZY Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205 [TBL] [Abstract][Full Text] [Related]
13. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing. Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
15. Structural contributions of blocked or grafted poly(2-dimethylaminoethyl methacrylate) on PEGylated polycaprolactone nanoparticles in siRNA delivery. Lin D; Huang Y; Jiang Q; Zhang W; Yue X; Guo S; Xiao P; Du Q; Xing J; Deng L; Liang Z; Dong A Biomaterials; 2011 Nov; 32(33):8730-42. PubMed ID: 21885115 [TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery. Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259 [TBL] [Abstract][Full Text] [Related]
17. Grafting of poly(ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA. Kano A; Moriyama K; Yamano T; Nakamura I; Shimada N; Maruyama A J Control Release; 2011 Jan; 149(1):2-7. PubMed ID: 20005270 [TBL] [Abstract][Full Text] [Related]
18. Novel symmetric amphiphilic dendritic poly(L-lysine)-b-poly(L-lactide)-b-dendritic poly(L-lysine) with high plasmid DNA binding affinity as a biodegradable gene carrier. Li Y; Cui L; Li Q; Jia L; Xu Y; Fang Q; Cao A Biomacromolecules; 2007 May; 8(5):1409-16. PubMed ID: 17458996 [TBL] [Abstract][Full Text] [Related]
19. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer. Wang Y; Liu P; Du J; Sun Y; Li F; Duan Y J Biomater Sci Polym Ed; 2013; 24(10):1219-32. PubMed ID: 23713424 [TBL] [Abstract][Full Text] [Related]
20. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells. Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]